CNR Institutional Research Information System

CERVELLO, MELCHIORRE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 780
AS - Asia 379
EU - Europa 81
Totale 1.240
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 780
SG - Singapore 363
IT - Italia 51
FI - Finlandia 22
CN - Cina 14
DE - Germania 3
NL - Olanda 3
AT - Austria 2
KR - Corea 2
Totale 1.240
Salva come PNG Salva come JPEG
Città #
Santa Clara 729
Singapore 265
Helsinki 22
Palermo 12
Forest City 5
Falkenstein 3
Amsterdam 2
Cavallino 2
Council Bluffs 2
Guangzhou 2
Phoenix 2
Seoul 2
Vienna 2
Ashburn 1
Cascina 1
Giulianova 1
Mammola 1
Milan 1
Pescara 1
Roccella Ionica 1
Rome 1
Springfield 1
Squillace 1
Totale 1.060
Salva come PNG Salva come JPEG
Nome #
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 21
Photoaging of polystyrene-based microplastics amplifies inflammatory response in macrophages 17
Identification of an LPS-Induced Chemo-Attractive Peptide from Ciona robusta 16
Gene expression profiling of MCF10A breast epithelial cells exposed to IOERT 16
New Insights into the Behavior of NHC-Gold Complexes in Cancer Cells 15
The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH 15
Cancer therapy and treatments during COVID-19 era 14
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy 14
Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview 12
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance. 11
Targeting the cancer initiating cell: The ultimate target for cancer therapy 10
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways 10
Gamma enolase expression as early marker of neuronal differentiation of murine neuroblastoma cells N-115 9
Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation 9
Effects of ectopic expression of NGAL on doxorubicin sensitivity 9
Cationic solid lipid nanoparticles complexed with genetic material for liver tumor treatment 9
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 9
Cationic Solid Lipid Nanoparticles as Non Viral Vectors for the Inhibition of Hepatocellular Carcinoma Growth by RNA Interference 9
Characterization of toposomes from sea urchin blastula cells: a cell organelle mediating cell adhesion and expressing positional information. 9
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals 9
Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. 9
Biocompatible Lipid Nanoparticles as Carriers to Improve Curcumin Efficacy in Ovarian Cancer Treatment 9
Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells 9
Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. 9
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells 8
Advances in targeting signal transduction pathways. 8
COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. 8
Emerging Use of Nanotechnology for the Treatment of Liver Diseases 8
Magnetic Nanoparticles tailored with Peptides/Amphiphilic Cyclodextrins assemblies: from Amyloid- detection to theranostic applications. 8
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine. 8
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mtor cascades which alter therapy response 8
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 8
Abilities of ?-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 8
Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway 7
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling 7
The clinical impact of an extra virgin olive oil enriched mediterranean diet on metabolic syndrome: Lights and shadows of a nutraceutical approach 7
Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis 7
RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma 7
The NUPR1/p73 axis contributes to sorafenib resistance in hepatocellular carcinoma 7
Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. 7
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines 7
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53 7
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. 7
The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. 7
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 7
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma 7
Nanoassemblies Based on Supramolecular Complexes of Nonionic Amphiphilic Cyclodextrin and Sorafenib as Effective Weapons to Kill Human HCC Cells 7
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. 7
Lipid nanocarriers containing sorafenib inhibit colonies formation into human hepatocarcinoma cells 7
Gene expression profiling of human liver cancer cells following celecoxib treatment. 7
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. 7
Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells 7
The novel NF-kB inhibitor DHMEQ suppresses the growth of human hepatic cancer cells through redox-dependent signaling. 7
Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population 7
Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells. 7
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 7
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma 7
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 7
Combination of DHMEQ and Celecoxib synergistically exert anti-tumoral effects in human hepatoma cells. 7
The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism 7
Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis 7
A new extracellular matrix protein of the sea urchin embryo with properties of a substrate adhesion molecule. 7
Development of nimesulide loaded solid lipid nanoparticles. 7
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 7
DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. 7
New Agents and Approaches for Targeting the RAS/RAF/MEK/ERK and PI3K/AKT/mTOR Cell Survival Pathways 6
New landscapes and horizons in hepatocellular carcinoma therapy. 6
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 6
The novel NF-kB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. 6
Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. 6
COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells. 6
Emerging Raf inhibitors. 6
Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. 6
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression 6
Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells 6
Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery 6
Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. 6
DHMEQ and Celecoxib synergistically exert anti-tumoral activities in human liver cancer cells. 6
The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population 6
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs 6
Non invasive tools for the diagnosis of liver cirrhosis 6
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells 6
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. 6
From targets to targeted therapies in Hepatocellular carcinoma 6
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 6
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health 6
Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. 6
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 6
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells 6
Induction of Apoptosis and Inhibition of Cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 6
Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma 6
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 6
Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. 6
Calcium-dependent self-aggregation of toposome, a sea urchin cell adhesion molecule. 6
Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors 6
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells 6
Transcriptional regulation of signature miRNAs 6
Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-±, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma. 6
Different aggregation properties of sea urchin cells at different developmental stages. II. Stage specific response to fibronectin and collagen. 6
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells 6
Totale 785
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.923
article - articoli 4.171
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 141
Totale 10.235
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202422 0 0 0 0 0 0 0 0 1 0 13 8
2024/20251.242 38 26 243 138 658 139 0 0 0 0 0 0
Totale 1.264